GCL
PEAR

Glazer Capital LLC’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Glazer Capital LLC’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-745,859
Closed -$7.41M – 972
2021
Q3 		$7.41M Buy
745,859
+1,664
+0.2% +$16.5K 0.13% 193
2021
Q2 		$7.35M Buy
+744,195
New +$7.35M 0.11% 228